Market Exclusive

Analyst Downgrades – Atara Biotherapeutics (NASDAQ:ATRA) Stock Gets Downgraded By Citigroup from Neutral to Sell

Analyst Ratings For Atara Biotherapeutics (NASDAQ:ATRA)

Today, Atara Biotherapeutics (NASDAQ:ATRA) stock was downgraded by Citigroup from Neutral to Sell.

Some recent analyst ratings include

Recent Insider Trading Activity For Atara Biotherapeutics (NASDAQ:ATRA)
Atara Biotherapeutics (NASDAQ:ATRA) has insider ownership of 16.20% and institutional ownership of 69.58%.

Recent Trading Activity for Atara Biotherapeutics (NASDAQ:ATRA)
Shares of Atara Biotherapeutics closed the previous trading session at 47.30 down -1.05 2.17% with 42.849998474121094 shares trading hands.

Exit mobile version